Qube Research & Technologies (QRT)
CDTX

Qube Research & Technologies (QRT)’s Cidara Therapeutics CDTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-358,432
Closed -$79.2M – 3581
2025
Q4 		$79.2M Buy
358,432
+322,549
+899% +$52.1M 0.08% 325
2025
Q3 		$3.44M Buy
+35,883
New +$2.29M ﹤0.01% 1971
2024
Q3 		– Sell
-2
Closed -$24 – 3392
2024
Q2 		$24 Sell
2
-1
-33% -$14 ﹤0.01% 3562
2024
Q1 		$48 Hold
3
– – ﹤0.01% 4220
2023
Q4 		$41 Sell
3
-170
-98% -$2.73K ﹤0.01% 4085
2023
Q3 		$3.25K Buy
+173
New +$3.4K ﹤0.01% 3514

Qube Research & Technologies (QRT)'s CDTX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 358,432 shares — an estimated $79.2M sold.

Qube Research & Technologies (QRT) first reported a position in CDTX in Q3 2023 and held it in 6 quarters. The position peaked at $79.2M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 358,432 Cidara Therapeutics shares in Q1 2026, an estimated $79.2M.
  • Qube Research & Technologies (QRT) first reported a position in Cidara Therapeutics in Q3 2023 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Cidara Therapeutics position peaked at $79.2M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.